Hasil Pencarian - J.-F. Boileau

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    P111 A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)

    P111 A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer... oleh N. Harbeck, J.-F. Boileau, S. Modi, C. Kelly, S. Ohno, J. Wu, A. Konpa, P. Herbolsheimer, S. Safdar, Y. Zhang, L. Pusztai

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study

    P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522... oleh S. Kümmel, P. Schmid, N. Harbeck, M. Takahashi, M. Untch, J.-F. Boileau, J. Cortes, H. McArthur, R. Dent, J. O’Shaughnessy, L. Pusztai, T. Foukakis, Y.H. Park, R. Hui, F. Cardoso, C. Denkert, Y. Zhu, W. Pan, V. Karantza, P. Fasching

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: